End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 CNY | 0.00% | -1.02% | +4.30% |
04-30 | Kangmei Pharmaceutical Logs Profit in Q1 | MT |
04-29 | Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 4.18B 579M 789M | Sales 2023 | 4.87B 675M 920M | Capitalization | 25.79B 3.57B 4.87B |
---|---|---|---|---|---|
Net income 2022 | -2.69B -372M -507M | Net income 2023 | 103M 14.27M 19.44M | EV / Sales 2022 | 7 x |
Net cash position 2022 | 1.24B 172M 235M | Net cash position 2023 | 802M 111M 151M | EV / Sales 2023 | 5.13 x |
P/E ratio 2022 |
-11.6
x | P/E ratio 2023 |
186
x | Employees | 4,409 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 67.98% |
1 week | -1.02% | ||
Current month | -2.51% | ||
1 month | +2.65% | ||
3 months | +4.30% | ||
6 months | +3.74% | ||
Current year | +4.30% |
Managers | Title | Age | Since |
---|---|---|---|
Guo Wei Liu
CEO | Chief Executive Officer | 51 | 20-10-09 |
Gui Bo Gong
DFI | Director of Finance/CFO | 50 | 20-10-09 |
Min Li
IRC | Investor Relations Contact | 35 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Ping Lai
BRD | Director/Board Member | 63 | 20-10-29 |
Yan Zhu Gao
CHM | Chairman | 59 | 20-10-29 |
Qi Mi
BRD | Director/Board Member | 62 | 22-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2,867 M€ | +10.77% | - | |
0.00% | 454 M€ | +9.62% | - | |
0.00% | 153 M€ | +8.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 1.94 | 0.00% | 55,943,980 |
24-05-15 | 1.94 | 0.00% | 61,119,930 |
24-05-14 | 1.94 | -1.52% | 124,373,700 |
24-05-13 | 1.97 | -1.50% | 65,882,050 |
24-05-10 | 2 | +2.04% | 97,065,500 |
End-of-day quote Shanghai S.E., May 15, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.30% | 3.73B | |
+32.36% | 694B | |
+31.03% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.81% | 239B | |
+10.03% | 209B | |
-3.23% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- 600518 Stock